191 related articles for article (PubMed ID: 2207360)
1. [Pharmacologic bases of chemotherapy of brain tumors in children].
Vassal G
Bull Cancer; 1990; 77(7):699-713. PubMed ID: 2207360
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy delivery issues in central nervous system malignancy: a reality check.
Muldoon LL; Soussain C; Jahnke K; Johanson C; Siegal T; Smith QR; Hall WA; Hynynen K; Senter PD; Peereboom DM; Neuwelt EA
J Clin Oncol; 2007 Jun; 25(16):2295-305. PubMed ID: 17538176
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery in primary and metastatic brain tumors: summary report of the seventh annual meeting of the Blood-Brain Barrier Disruption Consortium.
Doolittle ND; Abrey LE; Ferrari N; Hall WA; Laws ER; McLendon RE; Muldoon LL; Peereboom D; Peterson DR; Reynolds CP; Senter P; Neuwelt EA
Clin Cancer Res; 2002 Jun; 8(6):1702-9. PubMed ID: 12060607
[TBL] [Abstract][Full Text] [Related]
4. [The blood-brain barrier: implications for chemotherapy in brain tumors].
Boaziz C; Breau JL; Morère JF; Israël L
Pathol Biol (Paris); 1991 Oct; 39(8):789-95. PubMed ID: 1762838
[TBL] [Abstract][Full Text] [Related]
5. The blood-brain barrier and cancer: transporters, treatment, and Trojan horses.
Deeken JF; Löscher W
Clin Cancer Res; 2007 Mar; 13(6):1663-74. PubMed ID: 17363519
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours?
Kemper EM; Boogerd W; Thuis I; Beijnen JH; van Tellingen O
Cancer Treat Rev; 2004 Aug; 30(5):415-23. PubMed ID: 15245774
[TBL] [Abstract][Full Text] [Related]
7. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience.
Fortin D; Desjardins A; Benko A; Niyonsega T; Boudrias M
Cancer; 2005 Jun; 103(12):2606-15. PubMed ID: 15880378
[TBL] [Abstract][Full Text] [Related]
8. Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm.
Gerstner ER; Fine RL
J Clin Oncol; 2007 Jun; 25(16):2306-12. PubMed ID: 17538177
[TBL] [Abstract][Full Text] [Related]
9. Toxicity profile of delayed high dose sodium thiosulfate in children treated with carboplatin in conjunction with blood-brain-barrier disruption.
Neuwelt EA; Gilmer-Knight K; Lacy C; Nicholson HS; Kraemer DF; Doolittle ND; Hornig GW; Muldoon LL
Pediatr Blood Cancer; 2006 Aug; 47(2):174-82. PubMed ID: 16086410
[TBL] [Abstract][Full Text] [Related]
10. [Role of chemotherapy in the treatment of brain tumors].
Chastagner P; Sommelet D
Pediatrie; 1991; 46(1):47-58. PubMed ID: 1851283
[TBL] [Abstract][Full Text] [Related]
11. Blood-brain barrier and treatment of central nervous system tumors.
Wiranowska M
J Fla Med Assoc; 1992 Oct; 79(10):707-10. PubMed ID: 1460453
[TBL] [Abstract][Full Text] [Related]
12. Drug delivery to brain tumours: challenges and progress.
Ningaraj NS
Expert Opin Drug Deliv; 2006 Jul; 3(4):499-509. PubMed ID: 16822225
[TBL] [Abstract][Full Text] [Related]
13. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
[TBL] [Abstract][Full Text] [Related]
14. Blood-brain barrier and chemotherapeutic treatment of brain tumors.
de Vries NA; Beijnen JH; Boogerd W; van Tellingen O
Expert Rev Neurother; 2006 Aug; 6(8):1199-209. PubMed ID: 16893347
[TBL] [Abstract][Full Text] [Related]
15. Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats.
Erdlenbruch B; Jendrossek V; Kugler W; Eibl H; Lakomek M
Cancer Chemother Pharmacol; 2002 Oct; 50(4):299-304. PubMed ID: 12357304
[TBL] [Abstract][Full Text] [Related]
16. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
Juillerat-Jeanneret L
Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
[TBL] [Abstract][Full Text] [Related]
17. Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors.
Neuwelt EA; Rapoport SI
Fed Proc; 1984 Feb; 43(2):214-9. PubMed ID: 6692941
[TBL] [Abstract][Full Text] [Related]
18. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
[TBL] [Abstract][Full Text] [Related]
19. High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours.
Koukourakis MI; Koukouraki S; Fezoulidis I; Kelekis N; Kyrias G; Archimandritis S; Karkavitsas N
Br J Cancer; 2000 Nov; 83(10):1281-6. PubMed ID: 11044350
[TBL] [Abstract][Full Text] [Related]
20. Infusion rates and drug distribution in brain tumor models in rats.
Khan A; Jallo GI; Liu YJ; Carson BS; Guarnieri M
J Neurosurg; 2005 Jan; 102(1 Suppl):53-8. PubMed ID: 16206734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]